Metrics raised 1
- FY27 core business revenue growth guidance raised to 40–50% (from prior minimum 25–30%), targeting ~₹1,200 crores revenue
Event Participants
Executives
5 Ashish Poddar, Brahma Reddy Kasu, Nageswara Rao Kandula, Yasuyuki Ikeda
Analysts
12 Arvind, Chandresh, Darshan, Mani Shankar, Praveen, Rahul, Rahul Maheshwari, Raman KV, Rohit Ohri, Sandhya, Shiva, Vijay Mahadevia
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Total Income | ₹250 crores | 41% YoY growth; record quarter driven by core pharma/chemical engineering business |
| EBITDA | ₹44 crores | 27% YoY growth; EBITDA margin 17.5%, reflecting lower margin YoY due to investments in new GScale business and consumables reduction |
| Profit Before Tax | ₹36 crores | 26% YoY growth |
| Profit After Tax | ₹26 crores | 26% YoY growth |
| Order Book (Core Business) | ₹1,400 crores | Unexecuted order book; ~50% from CDMO segment, balance from pharma and chemical |
| Exports Share | 2–3% of revenue | Sharply lower QoQ due to global market uncertainty; management expects 5–6% in Q2 FY27 |
| Working Capital Days | ~220–240 days | Expected to decline below 200 days by September FY27; driven by stable inventory, higher customer advances, and improved collections |
Geographic & Segment Commentary
Core Pharma & Chemical Engineering: Strong momentum continuing with 40–50% growth expected for FY27, targeting ~₹1,200 crores revenue. Order book at ₹1,400 crores with ~50% from CDMO clients. Industry capex across pharma remains robust (estimated ₹70,000–80,000 crores market), and management sees significant headroom — company holds only ~1% market share. No geographic concentration issue; growth is pan-India.
Exports: Exports declined to 2–3% of revenue in Q1 due to global market uncertainty, though management expects recovery to 5–6% in Q2. Exports remain a strategic focus especially for new glass-lined products in Europe and U.S. markets.
Company-Specific & Strategic Commentary
GScale Energy Acquisition (AI Data Center Infrastructure): SETL is acquiring up to 51% stake in GScale Energy, targeting ₹250 crores revenue in FY27. Products include power systems, cooling skids, modular systems, and turnkey design-build solutions. Facility: 4 lakh sq ft acquired; 2 lakh sq ft in execution with robotic equipment arriving by mid-September; operations starting November. Working with 5 data center customers (3 global MNC hyperscalers, 2 Indian players), with LOIs in advanced stages. EBITDA margins expected at 23–25%. India data center market projected to grow 6x from 1.8 GW to 10.2–10.5 GW by 2030; ~65% of the ~₹1 lakh crore per GW capex goes to products. GScale model: 60–70% equipment manufactured in-house, targeting project timeline reduction from 24–36 months to 15–18 months.
GL Hakko Partnership (Japan): SETL invested ~₹71 crores for ~19% stake with right to increase to 51% in 2–3 years. Access to 70 years of Japanese glass lining technology — a unique moat. Three product lines: (1) shallow tube glass heat exchangers (India market ₹2,000 crores, global $2 billion) with pricing advantage (₹12–15 lakhs vs ₹30 lakhs earlier); (2) conductivity glass reactors (spark-testable, no global competitor); (3) low-leaching, high-corrosion glass for semiconductor-grade chemicals. Critical glass manufacturing stays in Japan for technology protection; India handles fabrication (20% value). GL Hakko current revenue ₹200 crores, target ₹400 crores in 2–3 years with 51% acquisition on reaching this milestone.
FY27 Consolidated Guidance: Total revenue guided at ~₹1,450 crores: ₹1,200 crores core business (40–50% growth) + ₹250 crores GScale.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Core Business Revenue | ~₹1,200 crores for FY27 | 40–50% growth over prior year; driven by pharma/CDMO capex cycle and strong order book; management confirmed minimum 25–30% growth for future years |
| GScale Revenue | ₹250 crores for FY27 | Backed by active negotiations with 5 data center customers; 2 lakh sq ft capacity operational from November; order conversions expected within current year |
| Consolidated Revenue | ~₹1,450 crores for FY27 | Combination of core business + GScale; segment change to "solution sales" model |
| EBITDA Margin | 17–18% (consolidated) | Management committed to maintaining this range; GScale expected at 23–25% EBITDA margin once ramped |
| GL Hakko Revenue | ₹400 crores in 2–3 years | From current ₹200 crores; growth via product basket expansion and Indian fabrication support |
| Working Capital Days | <200 days by September FY27 | Revenue growth without proportional inventory build; higher customer advances; improved collections |
| GScale ROI | ~20% expected | Management to provide detailed revenue and ROI guidance soon |
Risks & Constraints
| Risk | Context |
|---|---|
| GScale Revenue Execution | ₹250 crores revenue targeted from a new business with production starting only in November. Management cites active LOIs with 5 customers but no binding orders disclosed; achievement depends on timely facility commissioning and order conversion. |
| Export Volatility | Exports fell to 2–3% of revenue in Q1 due to global uncertainty and elevated shipping costs (reportedly up 4x). Management expects recovery to 5–6% in Q2, but persistent global market disruption could cap export contribution. |
| Key Man / Integration Risk | GScale business is led by Brahma Reddy Kasu (founder of GScale Group); 51% acquisition structure and successful integration of a new leadership team into SETL processes is untested. Management expressed confidence but no performance history exists. |
| Technology Protection / Offshoring | Glass manufacturing deliberately retained in Japan (critical parts) — not transferred to India. This creates supply chain dependency on Japan for key inputs, though it protects against IP leakage. Any disruption in Japan operations would impact SETL's product delivery. |
| Working Capital Stretch | Current 220–240 days working capital cycle is elevated; management targets <200 days by September. High growth in both businesses could strain cash flows if receivables or inventory don't behave as projected. |
| Competition in Glass Lining | Management claims no global competitor for conductivity glass and shallow tube heat exchangers; however, European and U.S. glass lining companies exist for low-leaching glass. Pricing advantage (50%+ cost reduction) mitigates competitive risk. |
Q&A Highlights
GScale Business Model and Revenue Visibility
- Question: What exactly will GScale do, what margins are expected, and when will revenue materialize? (Raman KV)
- Answer: GScale addresses the 6x growth in India's data center market (1.8 GW to 10.2–10.5 GW by 2030). Business includes power products, cooling products, modular/skid-mounted systems, and turnkey design-build solutions. Working actively with 5 data center customers (3 global hyperscalers, 2 Indian), with LOIs in advanced stages; targeting ₹250 crores revenue in FY27. (Brahma Reddy Kasu, Nageswara Kandula)
GScale Manufacturing vs. Assembly
- Question: Are you just an assembler of others' components, or a manufacturer? Why would global OEMs like Schneider/ABB share technology? (Vijay Mahadevia)
- Answer: GScale manufactures in-house — fabricating skids, PDUs, switchgear panels, and secondary fluid networks using components sourced from global OEMs under partnership/licensing. These are integrated as complete solutions, not mere assembly. DFMA (Design for Manufacturing and Assembly) approach allows parallel fabrication during civil construction, cutting project timelines from 24–36 months to 15–18 months. OEMs partner because they can't deliver integrated system-level solutions at GScale's scale. (Brahma Reddy Kasu, Nageswara Kandula)
GL Hakko Technology Uniqueness
- Question: Is there any technology barrier or competition for these glass-lined products? (Vijay Mahadevia)
- Answer: Three unique product lines: (1) shallow tube glass heat exchangers — sold at 50%+ price reduction (₹12–15 lakhs vs ₹30 lakhs), 80% manufactured in Japan to protect IP; (2) conductivity glass — unique spark-testable glass with corrosion resistance, no manufacturer in India or globally; (3) low-leaching glass (part-per-trillion leaching levels) for semiconductor-grade chemicals — recently secured a pilot plant order from a major Indian client. (Nageswara Kandula)
Semiconductor Grade Glass — Manufacturing Location
- Question: Is the semiconductor glass manufactured in-house at Hyderabad or in Japan? (Shiva)
- Answer: Glass is manufactured in Japan and imported; reactors are fabricated, glass-sprayed, and assembled in India. No technology transfer agreement currently exists — SETL deliberately retains critical glass technology in Japan for secrecy protection. (Nageswara Kandula)
Order Book and Growth Sustainability
- Question: What is the unexecuted order book and can 40–50% growth continue? (Rahul)
- Answer: Order book is ~₹1,400 crores after Q1 billing. Pharma CDMO capex cycle is strong; any pharma company must invest to grow. Industry capex is ₹70,000–80,000 crores and SETL holds ~1% share, providing massive headroom. "Sky is not the limit" — visibility is bright. (Nageswara Kandula)
FY27 Working Capital Improvement Drivers
- Question: What drives the working capital improvement from 220–240 days to below 200? (Rahul Maheshwari)
- Answer: Inventory is expected to stay flat despite revenue growth (no stock increase), customer advances are rising, and receivable collections are improving. GScale working capital is expected at even lower levels (below 150 days) due to advance payments and faster project delivery cycles. (Nageswara Kandula)
FY27 Revenue Guidance and GScale Trajectory
- Question: Can we extrapolate ₹250 crores GScale revenue into a 3x/4x number for FY28? (Rahul Maheshwari)
- Answer: Consolidated FY27 guidance is ₹1,450 crores (₹1,200 crores core + ₹250 crores GScale). Exact FY28 guidance will be provided once manufacturing is fully operational and customer LOIs convert. Minimum 25–30% core growth previously guided; this year revised upward to 40–50% on order book strength. (Nageswara Kandula)
EBITDA Margin Outlook
- Question: Is the margin decline temporary or structural? Can we expect recovery? (Sandhya, Rohit Ohri)
- Answer: Decline is due to mechanization investments in two units and consumables reduction — a transitionary impact. Management maintains 17–18% consolidated EBITDA margin guidance. GScale products and services expected at 23–25% EBITDA margin. Margin improvement expected through both operating and financial leverage. (Nageswara Kandula, Brahma Reddy Kasu)
Rationale for GScale Entry
- Question: How does AI data center business fit SETL's basket? (Rohit Ohri)
- Answer: Data centers evolved from telecom and pharma clean-room technologies. SETL already produces heat exchangers, boilers, SS skids, and power control systems used in pharma — highly similar products are required in data centers for precision cooling and power reliability. This is a natural adjacent market leveraging existing high-precision manufacturing capabilities. (Nageswara Kandula, Brahma Reddy Kasu)
FY28 Revenue Building Block ($3,000 crores question)
- Question: Can consolidated revenue reach ₹3,000 crores in FY28? (Mani Shankar)
- Answer: Management declined to give specific FY28 numbers but confirmed fundamentals and opportunities are very high; exact guidance will be announced when order visibility matures. (Nageswara Kandula)
Royalty / Licensing Structure
- Question: Is there any royalty obligation on these technology transactions? (Arvind)
- Answer: No royalty — GScale operates on a licensing model for technology. GL Hakko arrangement is stake-based (19% now, up to 51% later) with critical parts sourced from Japan. No royalty is being paid currently. (Nageswara Kandula, Brahma Reddy Kasu)
Key Takeaway
Standard Engineering Technology delivered a record Q1 FY27 with total income of ₹250 crores (41% YoY), EBITDA of ₹44 crores (27% YoY), and PAT of ₹26 crores (26% YoY), while concurrently building two new growth engines: GScale Energy (AI data center infrastructure, 51% acquisition, ₹250 crores FY27 revenue target, 23–25% EBITDA margin potential) and GL Hakko partnership in Japan (19% stake, ₹71 crores investment; shallow tube glass heat exchangers, conductivity glass, and semiconductor-grade glass-lined reactors with no global competitors). Core business order book stands at ₹1,400 crores with 50% from CDMO clients, supporting the upgraded FY27 core guidance of ₹1,200 crores (40–50% growth) — combined consolidated guidance of ₹1,450 crores. Management targets working capital compression below 200 days and maintains 17–18% EBITDA margin guidance. Key watch items include GScale's order conversion and November facility commissioning, export recovery from the current 2–3% level, and the planned GL Hakko stake increase to 51% contingent on its revenue doubling from ₹200 to ₹400 crores in 2–3 years.